drugset / Trial / NCT04457076

Evaluation of the Efficacy, Safety, and Tolerability of LevoCept

NCT04457076

Phase 3 Not yet recruiting 1525 enrolled Sebela Women's Health Inc. PRA Health Sciences · collab
NaSingle-groupOpen-labelTreatment

Summary

To assess the contraceptive efficacy (prevention of pregnancy) of LevoCept

Timeline

Start
2026-06-01
Primary completion
2030-06-01
Completion
2032-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule

Indications

No indication recorded.